site stats

Syros pharmaceuticals ticker

WebSyros Pharmaceuticals, Inc. (SYRS) Stock Price, News, Quote & History - Yahoo Finance U.S. markets open in 6 hours 59 minutes Dow Futures Nasdaq Futures Russell 2000 Futures … Find the latest Syros Pharmaceuticals, Inc. (SYRS) stock discussion in Yahoo … Discover historical prices for SYRS stock on Yahoo Finance. View daily, weekly or … Get the detailed quarterly/annual income statement for Syros Pharmaceuticals, … Find out the direct holders, institutional holders and mutual fund holders for … See the company profile for Syros Pharmaceuticals, Inc. (SYRS) including … See Syros Pharmaceuticals, Inc. (SYRS) stock analyst estimates, including … Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2024 Earnings Call … Find out all the key statistics for Syros Pharmaceuticals, Inc. (SYRS), including … View the basic SYRS option chain and compare options of Syros … Find the latest Syros Pharmaceuticals, Inc. (SYRS) stock quote, history, news and … WebAug 9, 2016 · SYRS - Syros Pharmaceuticals, Inc. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × …

Syros Pharmaceuticals To Acquire TYME Technologies Nasdaq

WebApr 10, 2024 · Support: 888-992-3836 Home NewsWire Subscriptions ... WebFind real-time SYRS - Syros Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. SYRS - Syros Pharmaceuticals Inc Stock quote - … shover racing https://olgamillions.com

SYRS Stock Price Syros Pharmaceuticals Inc. Stock …

WebFollowing my experience in 2016, I was invited to apply for the expo of 2024. Again I worked directly under the team that managed, organised and ran … WebJun 30, 2024 · Alarmingly, Syros's cash, cash equivalents, & short-term investments balance dwindled from $130.4 million as of December 31, 2024, to $86.3 million as of June 30, 2024. Also, year-over-year, Syros ... WebNov 7, 2024 · Based in Massachusetts, Syros Pharmaceuticals is a biopharmaceutical business with a market cap of around $82 million. It’s a small company, and sometimes a stock representing a business of this size makes a miraculous 5x or 10x move. On the other hand, it’s not unusual for these types of stocks to get cut in half or even worse than that. shoves synonyms

Syros Pharmaceuticals Stock (NASDAQ:SYRS), Analyst Ratings ... - Benzinga

Category:SYROS PHARMACEUTICALS, INC. : SYRS Stock Price

Tags:Syros pharmaceuticals ticker

Syros pharmaceuticals ticker

Quote :: Syros Pharmaceuticals, Inc. (SYRS)

WebSep 28, 2015 · Syros Pharmaceuticals announced that it has signed an exclusive license agreement with TMRC. The contract has been signed to develop and commercialise tamibarotene for cancer in North America and Europe. The product is a first-in-class selective agonist to retinoic acid receptor alpha, a nuclear hormone receptor that … WebMar 2, 2024 · Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing new standards of care for the frontline treatment of patients with …

Syros pharmaceuticals ticker

Did you know?

WebSep 16, 2024 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced the closing of its merger with Tyme Technologies, Inc., pursuant to which Syros acquired TYME, including its pipeline assets and net cash at closing of …

WebApr 6, 2024 · A high-level overview of Syros Pharmaceuticals, Inc. (SYRS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebJul 5, 2024 · (RTTNews) - Syros Pharmaceuticals (SYRS) and TYME Technologies, Inc. (TYME) announced that the companies have entered into a definitive merger agreement pursuant to which Syros will acquire...

Web1 day ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Syros Pharmaceuticals (SYRS) WebAt Syros, we have identified cancer patients with aberrant expression of genes that can be targeted with new therapies. We are focused on applying this approach to developing new …

WebOct 3, 2024 · Syros Pharmaceuticals News: Why SYRS Stock Is Shooting 16% Higher Today. By William White, InvestorPlace Writer Dec 18, 2024. Syros Pharmaceuticals (SYRS) news for Wednesday about plans for ...

WebFind real-time SYRS - Syros Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. shoverr tub refacingWeb© 2024 Syros Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy Terms of Use Sitemap Terms of Use Sitemap shoves off crossword clueWebSep 15, 2024 · Following the closing of the Merger, the combined company will trade on The Nasdaq Global Select Market under the ticker symbol “SYRS,” and will be led by Syros’ existing management team,... shoves offWebApr 10, 2024 · Ticker Symbol SYRS Full Company Profile Financial Performance In 2024, SYRS's revenue was $14.88 million, a decrease of -36.65% compared to the previous … shovespammingWebJul 5, 2024 · CAMBRIDGE, Mass. & BEDMINSTER, N.J.-- (BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, and TYME Technologies, Inc. (NASDAQ:TYME), today announced that the companies have entered into a definitive merger agreement pursuant to which Syros … shoves out of the way crosswordWebApr 12, 2024 · Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) posted its quarterly earnings data on Thursday, March, 2nd. The company reported ($1.28) EPS for the quarter, missing … shoves traductionWebSyros Pharmaceuticals has raised a total of $525.5M in funding over 9 rounds. Their latest funding was raised on Jul 5, 2024 from a Post-IPO Equity round. Syros Pharmaceuticals is registered under the ticker NASDAQ:SYRS . Their stock opened with $12.50 in its Jun 30, 2016 IPO. Syros Pharmaceuticals is funded by 18 investors. shoveytookchase